Given that increased inflammation in the periphery and the brain has been associated with the pathophysiology of PD,32–36 it is possible that LRRK2 may play a role in this process and serve as a regulator of inflammatory and immune responses that influence risk for age-related degeneration and risk for PD. This evidence concerns the gene LRRK2 and Parkinson disease.